Page last updated: 2024-10-18

dihydrolipoamide and Stomach Neoplasms

dihydrolipoamide has been researched along with Stomach Neoplasms in 1 studies

Stomach Neoplasms: Tumors or cancer of the STOMACH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, F1
Cao, K1
Wang, M1
Liu, Y1
Zhang, Y1

Other Studies

1 other study available for dihydrolipoamide and Stomach Neoplasms

ArticleYear
Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Humans; MicroRNAs; Peptide Initiation Factors; RNA, Circular; Saponins; Stomach Neoplasms; Thioctic

2022